85 related articles for article (PubMed ID: 28849107)
41. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival.
Liu T; Zhang H; Xiong J; Yi S; Gu L; Zhou M
Mol Cancer; 2015 Mar; 14():65. PubMed ID: 25888903
[TBL] [Abstract][Full Text] [Related]
43. Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients.
Trino S; Iacobucci I; Erriquez D; Laurenzana I; De Luca L; Ferrari A; Ghelli Luserna Di Rorà A; Papayannidis C; Derenzini E; Simonetti G; Lonetti A; Venturi C; Cattina F; Ottaviani E; Abbenante MC; Russo D; Perini G; Musto P; Martinelli G
Oncotarget; 2016 Mar; 7(11):12951-61. PubMed ID: 26887044
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway.
Li S; Li X; Zhao H; Gao M; Wang F; Li W
Mol Med Rep; 2015 Oct; 12(4):5482-6. PubMed ID: 26151241
[TBL] [Abstract][Full Text] [Related]
45. TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility.
Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
Cancer Genet Cytogenet; 2009 Nov; 195(1):31-6. PubMed ID: 19837266
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
48. Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.
Safa M; Tavasoli B; Manafi R; Kiani F; Kashiri M; Ebrahimi S; Kazemi A
Tumour Biol; 2015 May; 36(5):3919-30. PubMed ID: 25589462
[TBL] [Abstract][Full Text] [Related]
49. Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction.
Leão M; Soares J; Gomes S; Raimundo L; Ramos H; Bessa C; Queiroz G; Domingos S; Pinto M; Inga A; Cidade H; Saraiva L
Life Sci; 2015 Dec; 142():60-5. PubMed ID: 26475964
[TBL] [Abstract][Full Text] [Related]
50. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.
He X; Kong X; Yan J; Yan J; Zhang Y; Wu Q; Chang Y; Shang H; Dou Q; Song Y; Liu F
Tumour Biol; 2015 Mar; 36(3):1437-44. PubMed ID: 25663456
[TBL] [Abstract][Full Text] [Related]
51. Transcription of genes of p53-dependent apoptosis in acute leukaemia.
Racay P; Hatok J; Hudecek J; Chudej J; Jurecekova J; Dobrota D
Int J Mol Med; 2008 Dec; 22(6):833-9. PubMed ID: 19020783
[TBL] [Abstract][Full Text] [Related]
52. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
53. A novel TEL-AML1 fusion transcript involving the pro-apoptotic gene BCL-G in pediatric precursor B acute lymphoblastic leukemia.
Abdelhaleem M; Yi Q; Beimnet K; Hitzler J
Leukemia; 2006 Jul; 20(7):1294. PubMed ID: 16673018
[No Abstract] [Full Text] [Related]
54. RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2.
Wang X; Zhou M; Fu Y; Sun T; Chen J; Qin X; Yu Y; Jia J; Chen C
PLoS One; 2016; 11(3):e0152142. PubMed ID: 27008505
[TBL] [Abstract][Full Text] [Related]
55. The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.
Xu L; Wu H; Wu X; Li Y; He D
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e124-e128. PubMed ID: 28544358
[TBL] [Abstract][Full Text] [Related]
56. Cell signaling pathways for the regulation of GATA4 transcription factor: Implications for cell growth and apoptosis.
Suzuki YJ
Cell Signal; 2011 Jul; 23(7):1094-9. PubMed ID: 21376121
[TBL] [Abstract][Full Text] [Related]
57. Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia.
Hohtari H; Kankainen M; Adnan-Awad S; Yadav B; Potdar S; Ianevski A; Dufva O; Heckman C; Sexl V; Kytölä S; Mustjoki S; Porkka K
Hemasphere; 2022 Mar; 6(3):e701. PubMed ID: 35233509
[TBL] [Abstract][Full Text] [Related]
58. Recent research on the association between signal transducer and activator of transcription 5 and childhood acute lymphoblastic leukemia.
Duan YF; Wen FQ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Aug; 24(8):942-947. PubMed ID: 36036135
[TBL] [Abstract][Full Text] [Related]
59. The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer.
Yu W; Lin X; Leng S; Hou Y; Dang Z; Xue S; Li N; Zhang F
Transl Oncol; 2024 Jun; 46():102014. PubMed ID: 38843657
[TBL] [Abstract][Full Text] [Related]
60. The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.
Shafi O; Siddiqui G; Jaffry HA
BMC Cancer; 2023 Dec; 23(1):1245. PubMed ID: 38110859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
